VEGFA and neoplasm: Since our findings suggest that the noncanonical NF-κB pathway is activated in CRC blood vessels and may be acting as an alternative pathway promoting angiogenesis, especially when VEGF signaling is blocked, we postulated that targeting of NIK could impede this secondary mechanism contributing to tumor neovascularization.